Vinblastine attenuates endotoxin-induced impairment of CGMP-mediated pulmonary vasorelaxation

Brett C. Sheridan, Robert C. McIntyre, Daniel R. Meldrum, Joseph C. Cleveland, Jeanette Agrafojo, John H. Eisenach, David A. Fullerton

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


We tested the hypothesis that neutrophils contribute to endotoxin-induced impairment of endothelium-dependent and -independent cyclic guanosine monophosphate (cGMP)-mediated pulmonary vascular smooth muscle relaxation. Rats were studied 6 h after endotoxin (20 mg/kg, intraperitoneal) or saline (1 cc, intraperitoneal). Neutrophil-depleted rats were studied 4 days after administration of vinblastine (750 μg/kg, intravenous). Concentration-response curves were generated for acetylcholine and sodium nitroprusside in isolated pulmonary arterial rings (10-9 M to 10-6 M). The absolute neutrophil count of controls was 1050 ± 206 neutrophils/mL, and the absolute neutrophil count of vinblastine-treated rats was 100 ± 41 neutrophils/mL (p < .05 versus controls) and 25 ± 25 neutrophils/mL in vinblastine-treated rats receiving endotoxin (p < .05 versus control and endotoxin). Endotoxin-induced impairment of endothelium-dependent and -independent cGMP-mediated pulmonary vasorelaxation was significantly attenuated by prior treatment with vinblastine. We conclude that neutrophils contribute to the pathogenesis of endotoxin-induced impairment of cGMP-mediated pulmonary vascular smooth muscle relaxation.

Original languageEnglish (US)
Pages (from-to)35-38
Number of pages4
Issue number1
StatePublished - Jul 1996

ASJC Scopus subject areas

  • Emergency Medicine
  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Vinblastine attenuates endotoxin-induced impairment of CGMP-mediated pulmonary vasorelaxation'. Together they form a unique fingerprint.

Cite this